Kirklin, JK, Westaby, S, Blackstone, EH, Kirklin, JW, Chenoweth, DE, Pacifico, AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg
1983; 86: 845–857.
Wan, S, LeClerc, JL, Vincent, JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest
1997; 112: 676–692.
Edmunds, LH Jr. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg
1998; 66: S12–S16; discussion S25–S28.
Hoffman, TM, Wernovsky, G, Atz, AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation
2003; 107: 996–1002.
Kilger, E, Weis, F, Briegel, J, et al. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med
2003; 31: 1068–1074.
Ando, M, Park, IS, Wada, N, Takahashi, Y. Steroid supplementation: a legitimate pharmacotherapy after neonatal open heart surgery. The Ann Thorac Surg
2005; 80: 1672–1678.
Casey, LC. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg
1993; 56: S92–S96.
Drusin, LM, Engle, MA, Hagstrom, JW, Schwartz, MS. The postpericardiotomy syndrome: a six-year epidemiologic study. N Engl J Med
1965; 272: 597–602.
Tarnok, A, Schneider, P. Pediatric cardiac surgery with cardiopulmonary bypass: pathways contributing to transient systemic immune suppression. Shock
2001; 16: 24–32.
Chaney, MA. Corticosteroids and cardiopulmonary bypass: a review of clinical investigations. Chest
2002; 121: 921–931.
Paparella, D, Yau, TM, Young, E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg
2002; 21: 232–244.
el-Barbary, M, Khabar, KS. Soluble tumor necrosis factor receptor p55 predicts cytokinemia and systemic inflammatory response after cardiopulmonary bypass. Crit Care Med
2002; 30: 1712–1716.
Stayer, SA, Diaz, LK, East, DL, et al. Changes in respiratory mechanics among infants undergoing heart surgery. Anesth Analg
2004; 98: 49–55.
Duval, EL, Kavelaars, A, Veenhuizen, L, van Vught, AJ, van de Wal, HJ, Heijnen, CJ. Pro- and anti-inflammatory cytokine patterns during and after cardiac surgery in young children. Eur J Pediatr
1999; 158: 387–393.
Hasan, Z, Zaidi, I, Jamil, B, Khan, MA, Kanji, A, Hussain, R. Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis. BMC Immunol
2005; 6: 14.
Brunow de Carvalho, W, Fonseca, MC. Steroids use in pediatric cardiac surgery: more questions. Pediatr Crit Care Med
2007; 8: 503–504.
Janeway, CA Jr, Flavell, RA. Immunology at Yale. Immunol Res
1999; 19: 105–106.
Trotter, A, Mück, K, Grill, HJ, Schirmer, U, Hannekum, A, Lang, D. Gender-related plasma levels of progesterone, interleukin-8 and interleukin-10 during and after cardiopulmonary bypass in infants and children. Crit Care
2001; 5: 343–348.
Varan, B, Tokel, K, Mercan, S, Dönmez, A, Aslamaci, S. Systemic inflammatory response related to cardiopulmonary bypass and its modification by methyl prednisolone: high dose versus low dose. Pediatr Cardiol
2002; 23: 437–441.
Schroeder, VA, Pearl, JM, Schwartz, SM, Shanley, TP, Manning, PB, Nelson, DP. Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces postbypass inflammatory mediator expression. Circulation
2003; 107: 2823–2828.
Lindberg, L, Forsell, C, Jögi, P, Olsson, AK. Effects of dexamethasone on clinical course, C-reactive protein, S100B protein and von Willebrand factor antigen after paediatric cardiac surgery. Br J Anaesth
2003; 90: 728–732.
Checchia, PA, Backer, CL, Bronicki, RA, et al. Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass. Crit Care Med
2003; 31: 1742–1745.
Gessler, P, Hohl, V, Carrel, T, et al. Administration of steroids in pediatric cardiac surgery: impact on clinical outcome and systemic inflammatory response. Pediatr Cardiol
2005; 26: 595–600.
Niazi, Z, Flodin, P, Joyce, L, Smith, J, Mauer, H, Lillehei, RC. Effects of glucocorticosteroids in patients undergoing coronary artery bypass surgery. Chest
1979; 76: 262–268.
Wilson, NJ, Webber, SA, Patterson, MW, Sandor, GG, Tipple, M, LeBlanc, J. Double-blind placebo-controlled trial of corticosteroids in children with postpericardiotomy syndrome. Pediatr Cardiol
1994; 15: 62–65.
Iqbal, MP, Sharif, HM, Mehboobali, N, Yousuf, FA, Khan, AH, Sellke, FW. N-acetyl-B-D-glucosaminidase and inflammatory response after cardiopulmonary bypass. J Coll Physicians Surg Pak
2008; 18: 74–77.
Seghaye, MC, Engelhardt, W, Grabitz, RG, et al. Multiple system organ failure after open heart surgery in infants and children. Thorac Cardiovasc Surg
1993; 41: 49–53.
Mayumi, H, Zhang, QW, Nakashima, A, et al. Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. Ann Thorac Surg
1997; 63: 129–137.
Morton, JR, Hiebert, CA, Lutes, CA, White, RL. Effect of methylprednisolone on myocardial preservation during coronary artery surgery. Am J Surg
1976; 13: 419–422.
Yeh, TF, Lin, YJ, Lin, HC. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med
2004; 350: 1304–1313.
Bronicki, RA, Backer, CL, Baden, HP, Mavroudis, C, Crawford, SE, Green, TP. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg
2000; 69: 1490–1495.
Amanullah, M, Hasan, A, Roe, J, Dunning, J. Is prophylactic administration of steroids of benefit to children undergoing cardiac surgery?
Interact Cardiovasc Thorac Surg
2004; 3: 499–502.
Scrascia, G, Rotunno, C, Guida, P, et al. Perioperative steroids administration in pediatric cardiac surgery: a meta-analysis of randomized controlled trials. Pediatr Crit Care Med
2014; 15: 435–442.